Consider Transverse Myelitis as a Complication of a SARS-CoV-2 Vaccination

Finsterer, Josef; Matovu, Daniel

doi:10.3346/jkms.2022.37.e150

Cited by 2 publications

(2 citation statements)

References 4 publications

(6 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 6 However, there have been reports of adverse effects such as myocarditis, arrhythmia and transverse myelitis. 7 8 9 COVID-19 vaccination-induced hyperglycemia and related complications were also reported. 10 11 However, there have been scarce reports on type 1 diabetes triggered by COVID-19 vaccines in patients without diabetes.…”

Section: Introductionmentioning

confidence: 99%

Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination

2023

View full text Add to dashboard Cite

During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccination-induced hyperglycemia and related complications have been reported. However, there have been few reports of type 1 diabetes triggered by COVID-19 vaccines in subjects without diabetes. Here, we report the case of a 56-year-old female patient who developed hyperglycemia after the second dose of COVID-19 mRNA-based vaccination without a prior history of diabetes. She visited our hospital with uncontrolled hyperglycemia despite administration of oral hyperglycemic agents. Her initial glycated hemoglobin level was high (11.0%), and fasting serum C-peptide level was normal. The fasting serum C-peptide level decreased to 0.269 ng/mL 5 days after admission, and the anti-glutamic acid decarboxylase antibody was positive. The patient was discharged in stable condition with insulin treatment. To our knowledge, this is the first case of the development of type 1 diabetes without diabetic ketoacidosis after mRNA-based COVID-19 vaccination, and is the oldest case of type 1 diabetes development under such circumstances.

show abstract

Section: Introductionmentioning

confidence: 99%

Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination

2023

View full text Add to dashboard Cite

show abstract

“…Rare incidences of vaccine-associated myelin loss in the central nervous system (CNS) or the peripheral nervous system (PNS), including Bell’s palsy [ 143 , 164 , 165 , 166 ], GBS [ 143 , 155 , 167 , 168 ], myelitis [ 169 , 170 , 171 , 172 ], and multiple sclerosis have also been reported following COVID-19 vaccinations [ 173 , 174 , 175 ].…”

Section: Covid-19 Vaccines and Neurological Adverse Eventsmentioning

confidence: 99%

Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?

et al. 2023

View full text Add to dashboard Cite

According to the WHO, as of January 2023, more than 850 million cases and over 6.6 million deaths from COVID-19 have been reported worldwide. Currently, the death rate has been reduced due to the decreased pathogenicity of new SARS-CoV-2 variants, but the major factor in the reduced death rates is the administration of more than 12.8 billion vaccine doses globally. While the COVID-19 vaccines are saving lives, serious side effects have been reported after vaccinations for several premature non-communicable diseases (NCDs). However, the reported adverse events are low in number. The scientific community must investigate the entire spectrum of COVID-19-vaccine-induced complications so that necessary safety measures can be taken, and current vaccines can be re-engineered to avoid or minimize their side effects. We describe in depth severe adverse events for premature metabolic, mental, and neurological disorders; cardiovascular, renal, and autoimmune diseases, and reproductive health issues detected after COVID-19 vaccinations and whether these are causal or incidental. In any case, it has become clear that the benefits of vaccinations outweigh the risks by a large margin. However, pre-existing conditions in vaccinated individuals need to be taken into account in the prevention and treatment of adverse events.

show abstract

Consider Transverse Myelitis as a Complication of a SARS-CoV-2 Vaccination

Cited by 2 publications

References 4 publications

Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination

Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination

Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?

Contact Info

Product

Resources

About